Glenmark Pharmaceuticals (BOM:532296) Total Stockholders Equity : ₹78,479 Mil (As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Glenmark Pharmaceuticals Total Stockholders Equity?

Glenmark Pharmaceuticals's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₹78,479 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Glenmark Pharmaceuticals's Book Value per Share for the quarter that ended in Mar. 2024 was ₹278.11. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Glenmark Pharmaceuticals's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.16.

Glenmark Pharmaceuticals Total Stockholders Equity Historical Data

The historical data trend for Glenmark Pharmaceuticals's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Glenmark Pharmaceuticals Total Stockholders Equity Chart

Glenmark Pharmaceuticals Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Stockholders Equity

Get a 7-Day Free Trial

60,705.05

70,646.27

90,866.47

94,739.23

78,479.27

Glenmark Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															94,739.23	-	93,270.94	-	78,479.27

Glenmark Pharmaceuticals (BOM:532296) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Glenmark Pharmaceuticals's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(78479.27	-	0)	/	282.188
	=	278.11

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Glenmark Pharmaceuticals's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(10792.39	+	1516.91)	/	78479.27
	=	0.16

Glenmark Pharmaceuticals Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Glenmark Pharmaceuticals's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Glenmark Pharmaceuticals (BOM:532296) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Glenmark Pharmaceuticals Ltd (BOM:532296) » Definitions » Total Stockholders Equity

Traded in Other Exchanges

GLENMARK:India

Address

Glenmark House, B. D. Sawant Marg, Chakala, Off Western Express Highway, Andheri (East), Mumbai, IND, 400099

Website

https://www.glenmarkpharma.com

Glenmark Pharmaceuticals Ltd is a specialty and generic drug manufacturing company. The company's research and development activity is focused on generating intellectual property assets that will help address unmet medical needs. Glenmark's product categories include novel molecular entities, formulations, and API products. The company considers merger and acquisition investment to be a potential component for expanding its research, development, manufacturing, and marketing capabilities.

Glenmark Pharmaceuticals (BOM:532296) Headlines

No Headlines